Thymic Epithelial Cell Alterations and Defective Thymopoiesis Lead to Central and Peripheral Tolerance Perturbation in MHCII Deficiency.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2021
Historique:
received: 19 02 2021
accepted: 07 05 2021
entrez: 2 7 2021
pubmed: 3 7 2021
medline: 21 10 2021
Statut: epublish

Résumé

Major Histocompatibility Complex (MHC) class II (MHCII) deficiency (MHCII-D), also known as Bare Lymphocyte Syndrome (BLS), is a rare combined immunodeficiency due to mutations in genes regulating expression of MHCII molecules. MHCII deficiency results in impaired cellular and humoral immune responses, leading to severe infections and autoimmunity. Abnormal cross-talk with developing T cells due to the absence of MHCII expression likely leads to defects in thymic epithelial cells (TEC). However, the contribution of TEC alterations to the pathogenesis of this primary immunodeficiency has not been well characterized to date, in particular in regard to immune dysregulation. To this aim, we have performed an in-depth cellular and molecular characterization of TEC in this disease. We observed an overall perturbation of thymic structure and function in both MHCII

Identifiants

pubmed: 34211466
doi: 10.3389/fimmu.2021.669943
pmc: PMC8239840
doi:

Substances chimiques

Histocompatibility Antigens Class II 0
Homeodomain Proteins 0
Proteome 0
RAG-1 protein 128559-51-3

Types de publication

Journal Article Multicenter Study Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

669943

Informations de copyright

Copyright © 2021 Ferrua, Bortolomai, Fontana, Di Silvestre, Rigoni, Marcovecchio, Draghici, Brambilla, Castiello, Delfanti, Moshous, Picard, Taghon, Bordon, Schulz, Schuetz, Giliani, Soresina, Gennery, Signa, Dávila Saldaña, Delmonte, Notarangelo, Roifman, Poliani, Uva, Mauri, Villa and Bosticardo.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The handling editor declared a shared affiliation with one of the authors (CRM).

Références

PLoS One. 2012;7(12):e52591
pubmed: 23300712
Cell. 1991 Sep 6;66(5):1051-66
pubmed: 1909605
Hum Immunol. 1985 Jun;13(2):69-82
pubmed: 3874194
Blood Rev. 1996 Dec;10(4):242-8
pubmed: 9012922
Br J Haematol. 2006 Sep;134(5):510-6
pubmed: 16848795
Blood. 2003 May 1;101(9):3550-9
pubmed: 12506036
J Allergy Clin Immunol. 2014 Aug;134(2):269-75
pubmed: 25001848
Science. 1991 Sep 20;253(5026):1417-20
pubmed: 1910207
Genome Res. 2014 Dec;24(12):1918-31
pubmed: 25224068
News Physiol Sci. 2004 Jun;19:154-8
pubmed: 15143213
Lupus. 2006;15(9):570-6
pubmed: 17080911
J Immunol. 2012 Jan 1;188(1):497-503
pubmed: 22124120
Nat Immunol. 2015 Jul;16(7):737-45
pubmed: 26006015
J Immunol. 2010 Oct 15;185(8):4570-81
pubmed: 20861359
J Immunol. 2005 Jul 1;175(1):246-53
pubmed: 15972655
Cell. 2002 Apr;109 Suppl:S21-33
pubmed: 11983150
J Bone Miner Res. 2012 Dec;27(12):2501-10
pubmed: 22836362
Genome Biol. 2014;15(12):550
pubmed: 25516281
Nat Biotechnol. 2016 May;34(5):525-7
pubmed: 27043002
J Exp Med. 2013 Apr 8;210(4):675-81
pubmed: 23530124
J Pediatr. 1993 Dec;123(6):921-8
pubmed: 8229525
Immunity. 2008 Sep 19;29(3):423-37
pubmed: 18799149
Am J Physiol Gastrointest Liver Physiol. 2009 Feb;296(2):G135-46
pubmed: 19033538
Nat Immunol. 2007 Apr;8(4):351-8
pubmed: 17322887
Clin Immunol. 2019 Jun;203:125-133
pubmed: 31028919
EMBO Mol Med. 2017 Jun;9(6):835-851
pubmed: 28455312
Bioinformatics. 2015 Apr 1;31(7):986-90
pubmed: 25429061
Blood. 2011 Nov 10;118(19):5108-18
pubmed: 21908431
Eur J Immunol. 2016 Jan;46(1):22-33
pubmed: 26450177
Medicine (Baltimore). 2001 Nov;80(6):405-18
pubmed: 11704716
Immunity. 2006 Jun;24(6):729-739
pubmed: 16782029
Front Pediatr. 2019 Dec 11;7:516
pubmed: 31921728
J Allergy Clin Immunol. 2019 Jan;143(1):325-334.e2
pubmed: 29906526
J Immunol. 2005 May 1;174(9):5537-44
pubmed: 15843552
Arch Dis Child. 2000 Oct;83(4):356-9
pubmed: 10999878
Front Immunol. 2015 Jul 20;6:365
pubmed: 26257733
Blood. 2020 Mar 19;135(12):954-973
pubmed: 31932845
Genome Biol. 2016 Oct 24;17(1):219
pubmed: 27776542
Immunity. 2003 Apr;18(4):453-7
pubmed: 12705848
Front Immunol. 2015 Apr 07;6:138
pubmed: 25904912
Immunol Cell Biol. 2011 Jan;89(1):45-53
pubmed: 21042335
J Exp Med. 2007 Jul 9;204(7):1583-93
pubmed: 17562816
J Exp Med. 1995 Oct 1;182(4):993-1004
pubmed: 7561702
J Allergy Clin Immunol. 2013 Mar;131(3):831-9
pubmed: 23228244
Blood. 2011 Jan 6;117(1):145-55
pubmed: 20870901
Annu Rev Immunol. 2001;19:331-73
pubmed: 11244040
Clinics (Sao Paulo). 2012;67(5):425-9
pubmed: 22666784
PLoS One. 2014 Jul 10;9(7):e102284
pubmed: 25010693
J Immunol. 1997 Apr 15;158(8):3730-7
pubmed: 9103437
J Immunol. 2003 Oct 1;171(7):3394-400
pubmed: 14500633
Nat Rev Immunol. 2009 Sep;9(9):657-61
pubmed: 19704418
J Clin Invest. 2002 Jan;109(1):59-68
pubmed: 11781351
Immunity. 2015 Nov 17;43(5):896-908
pubmed: 26572061
Eur J Immunol. 2004 Mar;34(3):705-714
pubmed: 14991600
J Immunol. 2006 Dec 15;177(12):8307-14
pubmed: 17142726
J Pediatr. 1997 Mar;130(3):388-93
pubmed: 9063413
Nat Immunol. 2017 Feb;18(2):161-172
pubmed: 27941786
Immunity. 2008 Sep 19;29(3):451-63
pubmed: 18799151

Auteurs

Francesca Ferrua (F)

San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, Milan, Italy.
Pediatric Immunohematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Vita-Salute San Raffaele University, Milan, Italy.

Ileana Bortolomai (I)

San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, Milan, Italy.

Elena Fontana (E)

Human Genome Department, Humanitas Clinical and Research Center, Rozzano, Milan, Italy.
Milan Unit, Institute of Genetic and Biomedical Research, National Research Council (CNR), Milan, Italy.

Dario Di Silvestre (D)

Department of Biomedical Sciences, Institute for Biomedical Technologies-National Research Council (CNR), Milan, Italy.

Rosita Rigoni (R)

Human Genome Department, Humanitas Clinical and Research Center, Rozzano, Milan, Italy.
Milan Unit, Institute of Genetic and Biomedical Research, National Research Council (CNR), Milan, Italy.

Genni Enza Marcovecchio (GE)

San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, Milan, Italy.

Elena Draghici (E)

San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, Milan, Italy.

Francesca Brambilla (F)

Department of Biomedical Sciences, Institute for Biomedical Technologies-National Research Council (CNR), Milan, Italy.

Maria Carmina Castiello (MC)

San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, Milan, Italy.
Milan Unit, Institute of Genetic and Biomedical Research, National Research Council (CNR), Milan, Italy.

Gloria Delfanti (G)

Experimental Immunology Unit, Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Despina Moshous (D)

Department of Pediatric Immunology, Hematology and Rheumatology, Necker Children's Hospital, AP-HP, Paris, France.
Laboratory "Genome Dynamics in the Immune System", INSERM UMR1163, Université de Paris, Institut Imagine, Paris, France.

Capucine Picard (C)

Department of Pediatric Immunology, Hematology and Rheumatology, Necker Children's Hospital, AP-HP, Paris, France.
Centre d'Etude des Déficits Immunitaires, Necker-Enfants Malades Hospital, AP-HP, Paris, France.
Laboratory of Lymphocyte Activation and Susceptibility to EBV infection, Inserm UMR 1163, University Paris Descartes Sorbonne Paris Cité, Imagine Institute, Paris, France.

Tom Taghon (T)

Department of Diagnostic Sciences, Ghent University Hospital, Ghent University, Ghent, Belgium.

Victoria Bordon (V)

Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium.

Ansgar S Schulz (AS)

Department of Pediatrics, University Medical Center Ulm, Ulm, Germany.

Catharina Schuetz (C)

Department of Pediatrics, University Medical Center Ulm, Ulm, Germany.
Department of Pediatrics, Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

Silvia Giliani (S)

Cytogenetics and Medical Genetics Unit and "A. Nocivelli" Institute for Molecular Medicine, Spedali Civili Hospital, Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.

Annarosa Soresina (A)

Unit of Pediatric Immunology, Pediatrics Clinic, University of Brescia, ASST-Spedali Civili Brescia, Brescia, Italy.

Andrew R Gennery (AR)

Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
Department of Pediatric Immunology and HSCT, Great North Children's Hospital, Newcastle upon Tyne, United Kingdom.

Sara Signa (S)

Department of Pediatric Immunology and HSCT, Great North Children's Hospital, Newcastle upon Tyne, United Kingdom.
Autoinflammatory Diseases and Immunodeficiencies Center, IRCCS Istituto G. Gaslini, and Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, and Maternal and Children's Sciences, University of Genoa, Genoa, Italy.

Blachy J Dávila Saldaña (BJ)

Division of Blood and Marrow Transplantation, Children's National Hospital, Washington, DC, United States.

Ottavia M Delmonte (OM)

Laboratory of Clinical Immunology and Microbiology, NIAID, NIH, Bethesda, MD, United States.

Luigi D Notarangelo (LD)

Laboratory of Clinical Immunology and Microbiology, NIAID, NIH, Bethesda, MD, United States.

Chaim M Roifman (CM)

Division of Immunology & Allergy, Department of Pediatrics, The Hospital for Sick Children, the Canadian Centre for Primary Immunodeficiency and the University of Toronto, Toronto, ON, Canada.

Pietro Luigi Poliani (PL)

Department of Molecular and Translational Medicine, Pathology Unit, University of Brescia, Brescia, Italy.

Paolo Uva (P)

CRS4, Science and Technology Park Polaris, Pula, Cagliari, Italy.

Pier Luigi Mauri (PL)

Department of Biomedical Sciences, Institute for Biomedical Technologies-National Research Council (CNR), Milan, Italy.

Anna Villa (A)

San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, Milan, Italy.
Milan Unit, Institute of Genetic and Biomedical Research, National Research Council (CNR), Milan, Italy.

Marita Bosticardo (M)

San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, Milan, Italy.
Laboratory of Clinical Immunology and Microbiology, NIAID, NIH, Bethesda, MD, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH